動物の成長促進剤および運動能力増強剤市場

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2021年10月

動物の成長促進剤および運動能力増強剤市場:タイプ[抗生物質および非抗生物質（ホルモン、酸性化剤、飼料酵素、プロバイオティクス、プレバイオティクス、植物性）]、動物タイプ（家禽、豚、家畜、水産養殖）- 2026年までの世界予測

Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2026

–

–

The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period.

“The non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones.

“Poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
Based on animal type, the poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives.
“Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period”
Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.

A breakdown of the primary participants for the animal growth promoters and performance enhancers market referred to for this report is provided below:
•By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3–30%
•By Designation: C-level–27%, Director Level–18%, and Others–55%
•By Region: North America–50%, Europe–20%, Asia Pacific–15%, RoW- 15%

The prominent players in the animal growth promoters and performance enhancers market include Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd (South Africa), Novus International, Inc. (US), Associated British Foods plc (UK), Erber AG (Austria), Phibro Animal Health Corporation (US), Kemin Industries, Inc. (US), Zoetis Inc. (US), Nutreco N.V. (Netherlands), Novozymes A/S (Denmark), BASF SE (Germany), Evonik Industries AG (Germany), Bluestar Adisseo Company (China), Land O’Lakes, Inc. (US), Chr. Hansen (Denmark), Biomin Holding GmbH (Austria), Guangdong VTR Bio-Tech Co., Ltd. (China), and Lallemand Inc. (Canada).
Research Coverage:
The report analyzes the market for various animal growth promoters and performance enhancers and their adoption pattern. It aims at estimating the market size and future growth potential of the global animal growth promoters and performance enhancers market and different segments such as type, animal type and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
•Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global animal growth promoters and performance enhancers market
•Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global animal growth promoters and performance enhancers market
•Market Development: Comprehensive information on the lucrative emerging regions by type, animal type, and region
•Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global animal growth promoters and performance enhancers market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global animal growth promoters and performance enhancers market.

目次

1INTRODUCTION26
1.1OBJECTIVES OF THE STUDY26
1.2MARKET DEFINITION27
1.2.1INCLUSIONS AND EXCLUSIONS27
1.3MARKET SCOPE28
1.3.1MARKETS COVERED28
FIGURE 1ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET SEGMENTATION28
FIGURE 2ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY REGION29
1.4YEARS CONSIDERED FOR THE STUDY29
1.5CURRENCY30
TABLE 1STANDARD CURRENCY CONVERSION RATES30
1.6LIMITATIONS30
1.7STAKEHOLDERS31
1.8SUMMARY OF CHANGES31
2RESEARCH METHODOLOGY33
2.1RESEARCH DATA33
FIGURE 3RESEARCH DESIGN33
2.1.1SECONDARY DATA34
2.1.1.1Key data from secondary sources35
2.1.2PRIMARY DATA36
FIGURE 4PRIMARY SOURCES36
2.1.2.1Key data from primary sources37
2.1.2.2Key industry insights38
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS38
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION39
2.2MARKET SIZE ESTIMATION39
FIGURE 7MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS40
FIGURE 8REVENUE SHARE ANALYSIS ILLUSTRATION: ROYAL DSM N.V.40
FIGURE 9SUPPLY SIDE MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)41
FIGURE 10DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR42
FIGURE 11CAGR PROJECTIONS42
FIGURE 12TOP-DOWN APPROACH43
 
2.3MARKET BREAKDOWN & DATA TRIANGULATION44
FIGURE 13MARKET DATA TRIANGULATION METHODOLOGY44
2.4MARKET SHARE ESTIMATION45
2.5ASSUMPTIONS FOR THE STUDY45
2.6RISK ASSESSMENT46
3EXECUTIVE SUMMARY47
FIGURE 14ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)47
FIGURE 15NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)48
FIGURE 16ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)48
FIGURE 17GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET49
4PREMIUM INSIGHTS50
4.1ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW50
FIGURE 18CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH50
4.2ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2020)51
FIGURE 19NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 202051
4.3GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET52
FIGURE 20EUROPEAN COUNTRIES TO WITNESS HIGH CAGR DURING
THE FORECAST PERIOD52
4.4ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
REGIONAL MIX53
FIGURE 21ASIA PACIFIC IS THE LARGEST MARKET FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS53
5MARKET OVERVIEW54
5.1INTRODUCTION54
5.2MARKET DYNAMICS54
FIGURE 22ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES54
5.2.1DRIVERS55
5.2.1.1Increase in demand and consumption of livestock-based products55
TABLE 2PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS55
FIGURE 23ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)56
FIGURE 24ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)56
5.2.1.2Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters57
5.2.1.3Rise in the global demand for naturally produced growth promoters58
5.2.1.4Rise in awareness about growth promoters58
FIGURE 25US: ANTIBIOTICS SALES (2018)58
5.2.1.5Rise in animal epidemics and climate change59
5.2.2RESTRAINTS60
5.2.2.1Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals60
5.2.2.2Ban on antibiotics in different nations60
TABLE 3BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR61
5.2.3OPPORTUNITIES61
5.2.3.1Focus on increasing environmental sustainability61
5.2.4CHALLENGES62
5.2.4.1Increasing global feed tonnage and high feed costs
leading to the adoption of conventional feeding systems62
5.2.4.2Growing threat of disease transmission to and from agricultural animals63
6INDUSTRY INSIGHTS64
6.1INDUSTRY TRENDS64
6.1.1INVESTMENT TOWARDS NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS64
TABLE 4INVESTMENT TOWARDS ANIMAL GROWTH PROMOTERS64
6.1.2GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY64
TABLE 5MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017–2019)65
6.2PRICING ANALYSIS65
TABLE 6AVERAGE SELLING PRICE OF ANIMAL GROWTH PROMOTERS65
TABLE 7SIMULATION OF THE ECONOMIC IMPACT OF REMOVING ANTIBIOTIC GROWTH PROMOTERS (AGP)66
6.3VALUE CHAIN ANALYSIS66
FIGURE 26VALUE CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET67
6.4ECOSYSTEM MAPPING67
FIGURE 27ECOSYSTEM ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET68
6.5SUPPLY CHAIN ANALYSIS68
FIGURE 28SUPPLY CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET69
6.6PORTER’S FIVE FORCES ANALYSIS70
TABLE 8PORTERS FIVE FORCES ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)70
6.6.1INTENSITY OF COMPETITIVE RIVALRY70
6.6.2BARGAINING POWER OF SUPPLIERS70
6.6.3BARGAINING POWER OF BUYERS71
6.6.4THREAT OF NEW ENTRANTS71
6.6.5THREAT OF SUBSTITUTES71
6.7REGULATORY ANALYSIS72
FIGURE 29DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS74
FIGURE 30APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS IN EUROPE75
6.8PATENT ANALYSIS76
6.8.1PATENT PUBLICATION TRENDS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS76
FIGURE 31GLOBAL PATENT PUBLICATION TRENDS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, 2015–202076
6.9TRADE ANALYSIS77
TABLE 9IMPORT SHIPMENT RELATED TO ANIMAL GROWTH PROMOTERS77
6.10IMPACT OF THE COVID-19 PANDEMIC ON THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET77
7ANIMAL GROWTH PROMOTERS AND PERFORMANCE
ENHANCERS MARKET, BY TYPE79
7.1INTRODUCTION80
TABLE 10ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)80
7.2NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS80
TABLE 11NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)80
TABLE 12NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)81
7.2.1PREBIOTICS & PROBIOTICS81
7.2.1.1Prebiotics & probiotics hold the largest share of the market81
TABLE 13PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)82
7.2.2ACIDIFIERS83
7.2.2.1Regulations on antibiotics and wide applications in different production animals to drive the use of acidifiers83
TABLE 14ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)84
7.2.3PHYTOGENICS84
7.2.3.1Natural performance enhancement and antioxidative & disease defense properties to support the use of phytogenics84
TABLE 15PHYTOGENICS GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)85
7.2.4FEED ENZYMES85
7.2.4.1Feed enzymes segment to benefit from the bans on antibiotics and hormones85
 
TABLE 16FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)86
7.2.5HORMONES86
7.2.5.1Human health implications and restricted usage due to regulations to hamper the growth of the hormones segment86
TABLE 17HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)87
7.2.6OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS88
TABLE 18OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)89
7.3ANTIBIOTIC GROWTH PROMOTERS89
7.3.1ANTIBIOTIC GROWTH PROMOTERS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS89
TABLE 19PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US (2019)90
TABLE 20ANTIBIOTICS BANS AND REGULATIONS, BY COUNTRY91
TABLE 21ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)92
8ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE93
8.1INTRODUCTION94
TABLE 22ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)94
8.2POULTRY94
8.2.1THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 202094
TABLE 23IMPORTANT STATISTICS RELATED TO POULTRY MEAT (2020)95
TABLE 24ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)96
8.3LIVESTOCK96
8.3.1THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD96
TABLE 25ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION)97
8.4SWINE98
8.4.1RISING DEMAND FOR PORK MEAT AND THE INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAK TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS98
TABLE 26ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)99
8.5AQUATIC ANIMALS99
8.5.1GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS99
TABLE 27ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)100
 
8.6OTHER ANIMALS100
TABLE 28ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)101
9ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION102
9.1INTRODUCTION103
FIGURE 32ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD103
TABLE 29ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2019–2026 (USD MILLION)104
9.2ASIA PACIFIC105
FIGURE 33ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT105
TABLE 30ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)106
TABLE 31ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)106
TABLE 32ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)107
TABLE 33ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)107
9.2.1CHINA108
9.2.1.1China to dominate the APAC animal growth promoters and performance enhancers market108
TABLE 34CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)108
TABLE 35CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)109
TABLE 36CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)109
9.2.2INDIA110
9.2.2.1Large livestock population and increased production and export capacities to drive market growth110
TABLE 37INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)110
TABLE 38INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)111
TABLE 39INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)111
9.2.3JAPAN112
9.2.3.1Rising domestic meat demand and government efforts to encourage animal producers to drive the demand for growth promoters in Japan112
TABLE 40JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)112
TABLE 41JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)113
TABLE 42JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)113
9.2.4AUSTRALIA114
9.2.4.1Large cattle population and heavy meat exports to support the market in Australia114
TABLE 43AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)114
TABLE 44AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)115
TABLE 45AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)115
9.2.5REST OF ASIA PACIFIC116
9.2.5.1Lack of a defined regulatory scenario to result in the wide use of antibiotic growth promoters in the RoAPAC116
TABLE 46REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY116
TABLE 47ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)116
TABLE 48ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)117
TABLE 49ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)117
9.3NORTH AMERICA118
TABLE 50NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)118
TABLE 51NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)118
TABLE 52NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)119
TABLE 53NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)119
9.3.1US120
9.3.1.1Increasing meat consumption to drive the market in the US120
FIGURE 34US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS)120
TABLE 54US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)121
TABLE 55US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)121
TABLE 56US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)122
9.3.2CANADA122
9.3.2.1Production and export of meat and aquaculture in Canada to drive the market growth122
TABLE 57BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019123
TABLE 58CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)123
TABLE 59CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)124
TABLE 60CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)124
9.4EUROPE125
FIGURE 35EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT125
TABLE 61EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)126
TABLE 62EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)126
TABLE 63EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)126
TABLE 64EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)127
9.4.1UK127
9.4.1.1Preventive measures to avoid the risk of zoonotic diseases to drive the market in the UK127
TABLE 65UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)128
TABLE 66UK: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)128
TABLE 67UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)128
9.4.2GERMANY129
9.4.2.1Increasing veterinary visits and growing healthcare expenditure to boost the growth of the market in Germany129
FIGURE 36SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)129
TABLE 68GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)130
TABLE 69GERMANY: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)130
TABLE 70GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)130
9.4.3SWITZERLAND131
9.4.3.1Increasing milk demand to drive the market in Switzerland131
TABLE 71SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)131
TABLE 72SWITZERLAND: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)131
TABLE 73SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)132
9.4.4RUSSIA132
9.4.4.1Russia to hold the largest share of the European market due to its large poultry production132
TABLE 74RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)133
TABLE 75RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)133
TABLE 76RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)133
9.4.5REST OF EUROPE134
9.4.5.1Technological advancements and the strong trade industry to support the RoE market134
TABLE 77ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)134
TABLE 78ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)135
TABLE 79ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)135
9.5LATIN AMERICA136
TABLE 80LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)136
TABLE 81LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)136
TABLE 82LATIN AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)136
TABLE 83LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)137
9.5.1BRAZIL137
9.5.1.1Brazil to dominate the Latin American market for animal growth promoters and performance enhancers137
TABLE 84BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)137
TABLE 85BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)138
TABLE 86BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)138
9.5.2REST OF LATIN AMERICA138
9.5.2.1Strong demand for animal products and support initiatives to help the market in the RoLA138
TABLE 87ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)139
TABLE 88ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)139
TABLE 89ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)140
9.6MIDDLE EAST140
9.6.1INCREASING DEMAND FOR CHICKEN AND SEAFOOD TO CONTRIBUTE TO MARKET GROWTH IN THE MIDDLE EAST140
TABLE 90MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)140
TABLE 91MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)141
TABLE 92MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)141
 
9.7AFRICA141
9.7.1RELIANCE ON CONVENTIONAL LIVESTOCK PRODUCTION PRACTICES TO HAMPER THE MARKET GROWTH IN AFRICA141
TABLE 93AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)142
TABLE 94AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)142
TABLE 95AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)143
10COMPETITIVE LANDSCAPE144
10.1INTRODUCTION144
FIGURE 37KEY MARKET DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)144
10.2REVENUE ANALYSIS OF KEY MARKET PLAYERS145
FIGURE 38REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET145
10.3MARKET SHARE ANALYSIS145
FIGURE 39ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2020146
10.4COMPETITIVE SCENARIO147
10.4.1PRODUCT LAUNCHES147
TABLE 96ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: PRODUCT LAUNCHES (JANUARY 2018 TO AUGUST 2021)147
10.4.2DEALS148
TABLE 97ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DEALS (JANUARY 2018 TO AUGUST 2021)148
10.4.3OTHER DEVELOPMENTS149
TABLE 98ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)149
10.5COMPETITIVE BENCHMARKING150
10.5.1COMPANY FOOTPRINT FOR KEY PLAYERS150
10.5.2PRODUCT TYPE FOOTPRINT OF COMPANIES151
10.5.3ANIMAL TYPE FOOTPRINT OF COMPANIES152
10.5.4REGIONAL FOOTPRINT OF COMPANIES153
10.6GEOGRAPHIC FOOTPRINT OF COMPANIES154
10.6.1GEOGRAPHIC REVENUE MIX: KEY PLAYERS154
10.7ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
R&D EXPENDITURE155
10.7.1R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2019 VS. 2020)155
10.8COMPANY EVALUATION MATRIX155
10.8.1STARS156
10.8.2EMERGING LEADERS156
10.8.3PERVASIVE PLAYERS156
10.8.4EMERGING COMPANIES156
FIGURE 40ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: GLOBAL COMPANY EVALUATION MATRIX157
10.9COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)158
10.9.1PROGRESSIVE COMPANIES158
10.9.2STARTING BLOCKS158
10.9.3RESPONSIVE COMPANIES158
10.9.4DYNAMIC COMPANIES158
FIGURE 41ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS159
11COMPANY PROFILES160
11.1KEY PLAYERS160
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1CARGILL, INCORPORATED160
TABLE 99CARGILL, INCORPORATED: BUSINESS OVERVIEW160
11.1.2ROYAL DSM N.V.165
TABLE 100ROYAL DSM N.V.: BUSINESS OVERVIEW165
FIGURE 42COMPANY SNAPSHOT: ROYAL DSM N.V. (2020)166
11.1.3ELANCO ANIMAL HEALTH INCORPORATED170
TABLE 101ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW170
FIGURE 43COMPANY SNAPSHOT: ELANCO ANIMAL HEALTH INCORPORATED (2020)171
11.1.4BOEHRINGER INGELHEIM GROUP174
TABLE 102BOEHRINGER INGELHEIM GROUP: BUSINESS OVERVIEW174
FIGURE 44COMPANY SNAPSHOT: BOEHRINGER INGELHEIM GROUP (2020)175
11.1.5MERCK & CO., INC.178
TABLE 103MERCK & CO., INC.: BUSINESS OVERVIEW178
FIGURE 45COMPANY SNAPSHOT: MERCK & CO., INC. (2020)179
11.1.6ARCHER-DANIELS-MIDLAND COMPANY (ADM)182
TABLE 104ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OVERVIEW182
FIGURE 46COMPANY SNAPSHOT: ARCHER-DANIELS-MIDLAND COMPANY (2020)183
11.1.7BLUESTAR ADISSEO COMPANY188
TABLE 105BLUESTAR ADISSEO COMPANY: BUSINESS OVERVIEW188
FIGURE 47COMPANY SNAPSHOT: BLUESTAR ADISSEO COMPANY (2020)189
11.1.8ALLTECH CORPORATION191
TABLE 106ALLTECH CORPORATION: BUSINESS OVERVIEW191
11.1.9EVONIK INDUSTRIES AG194
TABLE 107EVONIK INDUSTRIES AG: BUSINESS OVERVIEW194
FIGURE 48COMPANY SNAPSHOT: EVONIK INDUSTRIES AG (2020)195
11.1.10VETOQUINOL S.A.197
TABLE 108VETOQUINOL S.A.: BUSINESS OVERVIEW197
 
11.2OTHER PLAYERS200
11.2.1BUPO ANIMAL HEALTH PTY LTD.200
TABLE 109BUPO ANIMAL HEALTH PTY LTD: BUSINESS OVERVIEW200
11.2.2NOVUS INTERNATIONAL, INC.202
TABLE 110NOVUS INTERNATIONAL, INC.: BUSINESS OVERVIEW202
11.2.3ASSOCIATED BRITISH FOODS PLC205
TABLE 111ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW205
FIGURE 49COMPANY SNAPSHOT: ASSOCIATED BRITISH FOODS PLC (2020)206
11.2.4ERBER AG208
TABLE 112ERBER AG: BUSINESS OVERVIEW208
11.2.5PHIBRO ANIMAL HEALTH CORPORATION211
TABLE 113PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW211
FIGURE 50COMPANY SNAPSHOT: PHIBRO ANIMAL HEALTH CORPORATION (2020)212
11.2.6KEMIN INDUSTRIES, INC.215
TABLE 114KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW215
11.2.7ZOETIS INC.219
TABLE 115ZOETIS INC.: BUSINESS OVERVIEW219
FIGURE 51COMPANY SNAPSHOT: ZOETIS INC. (2020)220
11.2.8NUTRECO N.V. (A WHOLLY-OWNED SUBSIDIARY OF SHV GROUP)222
TABLE 116NUTRECO N.V.: BUSINESS OVERVIEW222
FIGURE 52COMPANY SNAPSHOT: SHV GROUP (2020)223
11.2.9NOVOZYMES A/S226
TABLE 117NOVOZYMES A/S.: BUSINESS OVERVIEW226
FIGURE 53COMPANY SNAPSHOT: NOVOZYMES A/S (2020)227
11.2.10BASF SE229
TABLE 118BASF SE: BUSINESS OVERVIEW229
FIGURE 54COMPANY SNAPSHOT: BASF SE (2020)230
11.2.11LAND O’LAKES, INC.232
11.2.12CHR. HANSEN A/S233
11.2.13BIOMIN HOLDING GMBH234
11.2.14GUANGDONG VTR BIO-TECH CO., LTD.235
11.2.15LALLEMAND INC.236
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12APPENDIX237
12.1DISCUSSION GUIDE237
12.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL243
12.3AVAILABLE CUSTOMIZATIONS245
12.4RELATED REPORTS245
12.5AUTHOR DETAILS246

お問合せフォーム